Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study)

Journal of Human Hypertension

Volumn 18, Issue 6, 2004, Pages 417-422

  Gerdts, E ^a,g   Roman, M J ^b   Palmieri, V ^b   Wachtell, K ^c   Smith, G ^d   Nieminen, M S ^e   Dahlof B ^f   Devereux, R B ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age; Gender; Left ventricular hypertrophy

Indexed keywords

ATENOLOL; LOSARTAN;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATTENUATION; BODY MASS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PREVALENCE; PROTEINURIA; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC HYPERTENSION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATENOLOL; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS;

EID: 2942709847     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001718     Document Type: Article

References (31)

1. Roman MJ et al. Impact of arterial stiffening on left ventricular structure. Hypertension 2000; 36: 489-494.
2. Ganau A et al. Ageing induces left ventricular concentric remodeling in normotensive subjects. J Hypertens 1995; 13: 1818-1822.
3. Howard BV et al. Diabetes and coronary heart disease in American Indians: The Strong Heart Study. Diabetes 1996; 45(Suppl 3): S6-S13.
4. Gardin JM et al. Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 1997; 29: 1095-1103.
5. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
6. Omvik P, Gerdts E, Myking OL, Lund-Johansen P. Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. Am Heart J 2000; 140: 624-630.
7. Dahlöf B et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.
8. 9 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
9. Jensen JS et al. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant 1997; 12(Suppl 2): 6-9.
10. Devereux RB et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Blood Press 2001; 10: 74-82.
11. Wachtell K et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 2000; 85: 466-472.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results from a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
13. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Amer Soc Echocardiogr 1989; 2: 358-367.
14. Gutgesell HP, Paquet M, Duff DF, McNamara DG. Evaluation of left ventricular size and function by echocardiography. Results in normal children. Circulation 1977; 56: 457-462.
15. Reichek N, Devereux RB. Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J 1982; 103: 202-203.
16. Teichholz LE, Kroulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
17. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
18. Roman MJ et al. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996; 28: 751-756.
19. Devereux RB, Dahlof B, Levy D, Pfeffer MA. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 1996; 78: 61-65.
20. Gaasch WH et al. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79: 872-883.
21. de Simone G et al. Assessment of left ventricular function by the midwall fractional shortening/endsystolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444-1451, (Erratum, J Am Coll Cardiol 1994; 24 : 844.).
22. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990; 120: 116-123.
23. Lebowitz NE et al. Prevalence and correlates of aortic regurgitation in American Indians: the strong heart study. J Am Coll Cardiol 2000; 36: 461-467.
24. Jones EC et al. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 2001; 87: 298-304.
25. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 996-1004.
26. Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
27. Pannier B et al. Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens 1989; 7: 127-132.
28. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1991; 18: 1287-1294.
29. Gardin JM et al. Left ventricular diastolic filling in the elderly: the cardiovascular health study. Am J Cardiol 1998; 82: 345-351.
30. Zabalgoitia M et al. Disparity between diastolic mitral flow characteristics and left ventricular mass in essential hypertension. Am J Cardiol 1997; 79: 1255-1258.
31. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 1979; 237: H461-H468.